Benzodiazepines: Risks and benefits. A reconsideration
David S. Baldwin(University of Southampton), Sue Wilson(Imperial College London), H. Valerie Curran(MRC Cancer Unit), Katherine J. Aitchison(University of Alberta), David Stephens(University of Sussex), Alan N. Bateson(Dominica State College), David Nutt(Imperial College London), Brian E. Leonard(Maastricht University Medical Centre), Simon Davies(Centre for Addiction and Mental Health)
Cited by 236
Related Papers
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
|Psychopharmacology|2017|969
Neural correlates of the LSD experience revealed by multimodal neuroimaging
|Proceedings of the National Academy of Sciences|2016|880
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
|JAMA Psychiatry|2016|856
The dopamine theory of addiction: 40 years of highs and lows
|Nature reviews. Neuroscience|2015|653